- Home
- BVN vs PCVX Comparison
BVN vs PCVX Comparison
Compare BVN & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVN
- PCVX
- Stock Information
- Founded
- BVN 1953
- PCVX 2013
- Country
- BVN Peru
- PCVX United States
- Employees
- BVN N/A
- PCVX N/A
- Industry
- BVN Metal Mining
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- BVN Basic Materials
- PCVX Health Care
- Exchange
- BVN Nasdaq
- PCVX Nasdaq
- Market Cap
- BVN 6.2B
- PCVX 6.0B
- IPO Year
- BVN 1996
- PCVX 2020
- Fundamental
- Price
- BVN $22.96
- PCVX $48.57
- Analyst Decision
- BVN Hold
- PCVX Strong Buy
- Analyst Count
- BVN 1
- PCVX 7
- Target Price
- BVN $27.50
- PCVX $101.67
- AVG Volume (30 Days)
- BVN 1.4M
- PCVX 1.3M
- Earning Date
- BVN 10-30-2025
- PCVX 11-04-2025
- Dividend Yield
- BVN 1.27%
- PCVX N/A
- EPS Growth
- BVN 20.28
- PCVX N/A
- EPS
- BVN 1.70
- PCVX N/A
- Revenue
- BVN $1,407,837,000.00
- PCVX N/A
- Revenue This Year
- BVN $22.73
- PCVX N/A
- Revenue Next Year
- BVN $19.55
- PCVX N/A
- P/E Ratio
- BVN $13.75
- PCVX N/A
- Revenue Growth
- BVN 26.97
- PCVX N/A
- 52 Week Low
- BVN $11.50
- PCVX $27.66
- 52 Week High
- BVN $26.97
- PCVX $94.76
- Technical
- Relative Strength Index (RSI)
- BVN 49.60
- PCVX 68.68
- Support Level
- BVN $22.60
- PCVX $40.14
- Resistance Level
- BVN $23.94
- PCVX $49.87
- Average True Range (ATR)
- BVN 0.92
- PCVX 2.27
- MACD
- BVN 0.10
- PCVX 0.36
- Stochastic Oscillator
- BVN 64.07
- PCVX 88.50
About BVN Buenaventura Mining Company Inc.
Compania de Minas Buenaventura SAA is a Peruvian precious metals-producing company with experience in mine exploration, development, construction, and operation.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.